Data & Infrastructure Series A Investors & VC Firms
1334 firms in this list, with a median first check of $500K. 341 of them lead rounds. Generated from verified public data and updated continuously.
Windcrest Partners
New YorkSeed–Late Stage
3 people
World Innovation Lab (WiL)
Palo AltoPre-Seed–Late Stage$5M – $30M
XSeed Capital
Menlo ParkPre-Seed–Late Stage
3 people
YouNick Mint
Suchy LasPre-Seed–Series A$2.7M
3 people
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
New Ground Ventures
Palo AltoSeed–Series A
2 people
Ascend Venture Capital
SeattleSeed–Late Stage
2 people
Vibranium.VC
Menlo ParkPre-Seed–Series A$1M
2 people
BCP Ventures
DoverSeed–Series B
2 people
BSK Investment
SeoulSeed–Late Stage
2 people
East Gate Partners
SeoulSeed–Series A
2 people
Gaspar Global Ventures
New YorkSeed–Series B
2 people
Global Venture Capital, Inc.
TokyoSeed–Series A
2 people
i-Hatch Ventures LLC
New YorkSeed–Series A
2 people
Koyo Capital
BaarSeed–Series A
2 people
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
New Technology Ventures
Newton Lower FallsSeed–Series A
2 people
Shenzhen Leaguer Tsing-Yuan Venture Capital Management Co., Ltd.
ShenzhenSeed–Series B
2 people
Trellis Capital Corporation
TorontoSeries A–Series B
2 people
Trellis Partners
Cedar CreekSeed–Late Stage
2 people
Vestel Ventures
IstanbulSeed–Series A
2 people
Wild Basin Investments
TexasSeed–Growth
2 people
Xandex Ventures
PetalumaSeed–Series A
2 people
ALLEGIS CAPITAL
Palo AltoSeed–Series B$10M
Related lists
Series A Investors & VC Firms (7875)Series A Investors & VC Firms in United States (3337)SaaS Series A Investors & VC Firms (2667)AI & Machine Learning Series A Investors & VC Firms (2343)Enterprise Software Series A Investors & VC Firms (2324)Fintech Series A Investors & VC Firms (2239)Healthtech Series A Investors & VC Firms (2210)Series A Investors & VC Firms in Global (2163)Data & Infrastructure Investors & VC Firms (1702)Consumer Series A Investors & VC Firms (1652)
Data sourced from public filings and firms' own websites — see our methodology.

